Daniel Auclair

Daniel Auclair

UNVERIFIED PROFILE

Are you Daniel Auclair?   Register this Author

Register author
Daniel Auclair

Daniel Auclair

Publications by authors named "Daniel Auclair"

Are you Daniel Auclair?   Register this Author

38Publications

1824Reads

42Profile Views

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.

Nat Commun 2019 04 23;10(1):1911. Epub 2019 Apr 23.

Department of Hematology and Medical Oncology, Emory University School of Medicine, 1365 Clifton Rd. NE, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-09555-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478743PMC
April 2019

Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.

Cancer Discov 2014 Feb 23;4(2):216-31. Epub 2014 Jan 23.

1Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, NIH; 2Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland; 3Broad Institute of MIT and Harvard, Cambridge; 4Medical Oncology and Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Department of Pathology, Harvard Medical School, Boston, Massachusetts; 6University of Nebraska Medical Center, Omaha, Nebraska; 7Department of Pediatrics, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas; and 8Department of Pediatrics, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; 9The Tumour Bank, The Children's Cancer Research Unit, The Children's Hospital at Westmead, Westmead, New South Wales, Australia; 10Department of Oncology, Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462130PMC
February 2014

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.

Cancer Cell 2014 Jan;25(1):91-101

Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02412, USA; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2013.12.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241387PMC
January 2014

DNA methylation analysis determines the high frequency of genic hypomethylation and low frequency of hypermethylation events in plasma cell tumors.

Cancer Res 2010 Sep 24;70(17):6934-44. Epub 2010 Aug 24.

The Translational Genomics Research Institute, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-0282DOI Listing
September 2010

Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.

Breast Cancer Res Treat 2003 Feb;77(3):245-52

Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, MA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1023/A:1021899904332
Web Search
http://dx.doi.org/10.1023/a:1021899904332DOI Listing
February 2003

Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays.

Oncogene 2002 Feb;21(9):1346-58

The Jerome Lipper Multiple Myeloma Center, Department of Adult Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, MA 02115, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/1205205
Publisher Site
http://dx.doi.org/10.1038/sj.onc.1205205DOI Listing
February 2002

Novel chemiluminescence assay for serum periostin levels in women with preeclampsia and in normotensive pregnant women.

Am J Obstet Gynecol 2002 Jan;186(1):103-8

Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/mob.2002.118157DOI Listing
January 2002